Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment regimens using anti-NKG2A antibodies

Treatment regimens using anti-NKG2A antibodies

US Patent 12037392 · Granted Jul 16, 2024

Estimated economic value: $176,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of T cell lymphoma2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
NKp46 binding agents2025
NKp46 binding agents2025
Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of 2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Treatment of peripheral T cell lymphoma2024
Treatment with anti-KIR3DL2 agents2024
CD73 blockade2024
KIR3DL2 binding agents2024
Heterodimeric Fc-fused proteins2023